Inclusion Criteria:

• * Adults ≥18 years of age
• * History of atopic dermatitis, according to American Academy of Dermatology criteria, that has been present for at least 6 months
• * Mild, moderate, or severe atopic dermatitis, defined as an IGA score of ≥2 at Baseline
• * Not pregnant, breastfeeding, or lactating and agree to use a highly effective method of acceptable contraceptive for the trial duration, if applicable

Exclusion Criteria:

• * Presence of clinically significant kidney disease or an estimated gloverular filtration rate (eGFR) of less than or equal to 45 milliliters/min/1.73 m2 during screening
• * History of any unstable chronic diseases/conditions, clinically significant abnormalities, or findings, that in the opinion of the Investigator, could compromise subject safety or affect the conduct of the trial